175 related articles for article (PubMed ID: 36201890)
21. A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.
Francis OL; Milford TA; Martinez SR; Baez I; Coats JS; Mayagoitia K; Concepcion KR; Ginelli E; Beldiman C; Benitez A; Weldon AJ; Arogyaswamy K; Shiraz P; Fisher R; Morris CL; Zhang XB; Filippov V; Van Handel B; Ge Z; Song C; Dovat S; Su RJ; Payne KJ
Haematologica; 2016 Apr; 101(4):417-26. PubMed ID: 26611474
[TBL] [Abstract][Full Text] [Related]
22. Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-positive patients lacking CD4+ gain on antiviral therapy.
Bellistrì GM; Casabianca A; Merlini E; Orlandi C; Ferrario G; Meroni L; Galli M; Magnani M; Monforte Ad; Marchetti G
PLoS One; 2010 Dec; 5(12):e15663. PubMed ID: 21209878
[TBL] [Abstract][Full Text] [Related]
23. The survival and differentiation of pro-B and pre-B cells in the bone marrow is dependent on IL-7Rα Tyr449.
Patton DT; Plumb AW; Abraham N
J Immunol; 2014 Oct; 193(7):3446-55. PubMed ID: 25143441
[TBL] [Abstract][Full Text] [Related]
24. IL-7/STAT5 cytokine signaling pathway is essential but insufficient for maintenance of naive CD4 T cell survival in peripheral lymphoid organs.
Seki Y; Yang J; Okamoto M; Tanaka S; Goitsuka R; Farrar MA; Kubo M
J Immunol; 2007 Jan; 178(1):262-70. PubMed ID: 17182563
[TBL] [Abstract][Full Text] [Related]
25. Dual effect of IL-7/IL-7R signalling on the osteoimmunological system: a potential therapeutic target for rheumatoid arthritis.
Xu H; Cai L; Li Z; Zhang L; Wang G; Xie R; Jiang Y; Yuan Y; Nie H
Immunology; 2021 Sep; 164(1):161-172. PubMed ID: 33934341
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia.
Zenatti PP; Ribeiro D; Li W; Zuurbier L; Silva MC; Paganin M; Tritapoe J; Hixon JA; Silveira AB; Cardoso BA; Sarmento LM; Correia N; Toribio ML; Kobarg J; Horstmann M; Pieters R; Brandalise SR; Ferrando AA; Meijerink JP; Durum SK; Yunes JA; Barata JT
Nat Genet; 2011 Sep; 43(10):932-9. PubMed ID: 21892159
[TBL] [Abstract][Full Text] [Related]
27. IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells.
Shenoy AR; Kirschnek S; Häcker G
Eur J Immunol; 2014 Aug; 44(8):2500-7. PubMed ID: 24825007
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma.
Silva A; Almeida ARM; Cachucho A; Neto JL; Demeyer S; de Matos M; Hogan T; Li Y; Meijerink J; Cools J; Grosso AR; Seddon B; Barata JT
Blood; 2021 Sep; 138(12):1040-1052. PubMed ID: 33970999
[TBL] [Abstract][Full Text] [Related]
29. RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines.
Ksionda O; Melton AA; Bache J; Tenhagen M; Bakker J; Harvey R; Winter SS; Rubio I; Roose JP
Oncogene; 2016 Jul; 35(28):3658-68. PubMed ID: 26549032
[TBL] [Abstract][Full Text] [Related]
30. Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia.
Juarez J; Baraz R; Gaundar S; Bradstock K; Bendall L
Haematologica; 2007 Apr; 92(4):450-9. PubMed ID: 17488655
[TBL] [Abstract][Full Text] [Related]
31. A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.
Bayer AL; Lee JY; de la Barrera A; Surh CD; Malek TR
J Immunol; 2008 Jul; 181(1):225-34. PubMed ID: 18566388
[TBL] [Abstract][Full Text] [Related]
32. IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells.
Fung MM; Rohwer F; McGuire KL
Cell Signal; 2003 Jun; 15(6):625-36. PubMed ID: 12681450
[TBL] [Abstract][Full Text] [Related]
33. PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: new options for targeted therapy.
Martelli AM; Tabellini G; Ricci F; Evangelisti C; Chiarini F; Bortul R; McCubrey JA; Manzoli FA
Adv Biol Regul; 2012 Jan; 52(1):214-27. PubMed ID: 21983557
[No Abstract] [Full Text] [Related]
34. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
Ribeiro D; Melão A; van Boxtel R; Santos CI; Silva A; Silva MC; Cardoso BA; Coffer PJ; Barata JT
Blood Adv; 2018 Sep; 2(17):2199-2213. PubMed ID: 30185437
[TBL] [Abstract][Full Text] [Related]
35. Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.
Zeng H; Yu M; Tan H; Li Y; Su W; Shi H; Dhungana Y; Guy C; Neale G; Cloer C; Peng J; Wang D; Chi H
Sci Adv; 2018 Jan; 4(1):eaar5701. PubMed ID: 29399633
[TBL] [Abstract][Full Text] [Related]
36. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract][Full Text] [Related]
37. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
Roifman CM; Zhang J; Chitayat D; Sharfe N
Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway.
Lindemann MJ; Hu Z; Benczik M; Liu KD; Gaffen SL
J Biol Chem; 2008 May; 283(20):14100-8. PubMed ID: 18348982
[TBL] [Abstract][Full Text] [Related]
39. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
[TBL] [Abstract][Full Text] [Related]
40. STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Tremblay CS; Saw J; Boyle JA; Haigh K; Litalien V; McCalmont H; Evans K; Lock RB; Jane SM; Haigh JJ; Curtis DJ
Blood; 2023 Jul; 142(3):274-289. PubMed ID: 36989489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]